Cargando…
Absorbing filter AN69 surface treatment in critically ill COVID-19 patients: a single-center experience
Autores principales: | Chen, Gang, Ma, Jie, Xia, Peng, Hu, Yan, Liu, Zhengyin, Zhou, Xiang, Li, Taisheng, Yan, Xiaowei, Chen, Limeng, Li, Xuemei, Qin, Yan, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583914/ https://www.ncbi.nlm.nih.gov/pubmed/34751601 http://dx.doi.org/10.1080/0886022X.2021.1997763 |
Ejemplares similares
-
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
por: Ma, Jie, et al.
Publicado: (2020) -
Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study
por: Qian, Hao, et al.
Publicado: (2021) -
Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19)
por: Gao, Peng, et al.
Publicado: (2021) -
Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients
por: Liu, Yanan, et al.
Publicado: (2021) -
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
por: Zhang, Yan, et al.
Publicado: (2020)